Home / Health / Newborns: Genetic Rare Disease Study Launched
Newborns: Genetic Rare Disease Study Launched
8 Oct
Summary
- Study aims to identify over 200 rare, treatable genetic conditions.
- Genomic sequencing uses a small blood sample from newborns.
- University Hospital Southampton is a key contributor to the study.
A significant study is underway, encouraging mothers to enroll their newborn babies to help identify over 200 rare yet treatable genetic conditions. This initiative, known as the Generation Study, is a collaborative effort between Genomics England and NHS England.
The study utilizes genomic sequencing, a process that analyzes a baby's DNA from a small blood sample typically collected from the umbilical cord shortly after birth. University Hospital Southampton is a key participant in this scheme.
This testing, offered at Princess Anne Hospital, is both free and safe. Early diagnosis through this method can lead to prompt treatment, significantly improving health outcomes for newborns with identified conditions.
Mothers like Amy Thorpe have participated, stating their desire to enhance knowledge and support future treatment development. The broader aim is to screen 100,000 newborns across England.
